A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The primary goal of the study is to determine if orlistat 60mg (Alli) is effective in helping
patients achieve a required 10% weight loss goal prior to bariatric surgery. The medication
will be added to the usual standard of care which includes education regarding diet and
exercise and monthly meetings with a registered dietician.